Keros Therapeutics, Inc. (KROS)
19.20
+0.62
(+3.34%)
USD |
NASDAQ |
Jan 09, 16:00
19.19
-0.01
(-0.05%)
After-Hours: 20:00
Keros Therapeutics Accounts Payable (Quarterly): 2.298M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.262B |
| Pfizer Inc. | 5.024B |
| Innoviva, Inc. | 6.243M |
| Ocugen, Inc. | 4.574M |
| Bionano Genomics, Inc. | 5.99M |